Paul Surdez
Investor Relations Contact bei CATALENT, INC.
Profil
Paul Surdez is currently the Vice President-Investor Relations at Catalent, Inc. He previously held the same position at Laboratory Corp.
of America Holdings and Labcorp Drug Development, Inc.
Aktive Positionen von Paul Surdez
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALENT, INC. | Investor Relations Contact | 07.01.2020 |
Ehemalige bekannte Positionen von Paul Surdez
| Unternehmen | Position | Ende |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Investor Relations Contact | - |
| COVANCE INC. | Investor Relations Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| CATALENT, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
